Atezolizumab and Recombinant Human Hyaluronidase Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of atezolizumab and recombinant human hyaluronidase that can be used in the treatment of bladder cancer, cervical cancer, colon cancer, non-small cell lung cancer (NSCLC), alveolar soft part sarcoma (ASPS), small cell lung cancer (SCLC), hepatocellular carcinoma (HCC), peritoneal mesothelioma, cutaneous melanoma, and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and small bowel adenocarcinoma.

**Synonyms:** - Atezolizumab and Hyaluronidase-tqjs Regimen - Tecentriq Hybreza Regimen